RXISK Issues $100,000 Prize for the Cure For PSSD

Topics related to activism.
fasttrack1982
Posts: 122
Joined: Sat Oct 24, 2015 5:12 pm
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by fasttrack1982 »

Great job fema4psyciatrists! It is great that you are doing things in the real world to further awareness of our condition. I also applaud for being willing to reveal your identity, as many of us still embarrassed or too private to do so. If we want to create awareness, we have to stop hiding behind our computers.
fema4psyciatrists
Posts: 480
Joined: Sun Apr 24, 2016 4:46 pm
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by fema4psyciatrists »

Mad In America -- email list

https://education.madinamerica.com/p/ps ... hdrawal-ii

"
Dear ___

The next webinar in our Psychiatric Drug Withdrawal II webinar series is coming up!

The webinar will be presented by Dr. David Healy and Johanna Ryan, who will discuss SSRIs and sexual dysfunction. It will take place on Tuesday, September 18th, at 1:30pm Eastern, 10:30am Pacific.

All seminars in the series will be recorded and may be viewed at a time of your choosing. Click here to register for the series.

WEBINARS

June 19, 2018: Robert Whitaker Town Hall
1:30-3pm Eastern, 10:30-noon Pacific
Town Hall discussion on key issues from 3 perspectives: a psychiatrist, a psychologist and a person with lived experience in withdrawing.

July 17, 2018: Joanna Moncrieff, MD
1:30-3pm Eastern, 10:30-noon Pacific
The nature of psychiatric drugs, what we know and don't know about what they do to the brain with repeated and long-term use and how these changes affect the experience of withdrawal; study on antidepressant withdrawal and antipsychotic withdrawal.

August 21, 2018: Sandy Steingard, MD
1:30-3pm Eastern, 10:30-noon Pacific
Working in a public health clinic: what are the barriers to providing clients with withdrawal information and support for those who want to taper from the medications? What has she learned since she implemented a withdrawal program six years ago?

September 18, 2018: David Healy, MD and Johanna Ryan
1:30-3pm Eastern, 10:30-noon Pacific
SSRIs and sexual dysfunction: A look at this adverse effect during SSRI use, and PSSD: sexual dysfunction that persists after withdrawal, and what this may signal regarding renormalization of serotonergic function.

October 16, 2018: Sami Timimi, MD
1:30-3pm Eastern, 10:30-noon Pacific
Withdrawal issues with children and adolescents, challenges and opportunities

November 20, 2018: Swapnil Gupta, MD
1:30-3pm Eastern, 10:30-noon Pacific
Applying the basic principles of deprescribing to psychiatry: An intervention aimed at reducing the use of inappropriate medications, deprescribing was initially introduced by the field of geriatric medicine. In this talk, Dr. Gupta will discuss how deprescribing can serve as a model to reduce the superfluous use of psychotropic medications and how it can be modified for use in psychiatric settings.

December 11, 2018: Pesach Lichtenberg, MD
10:30-noon Eastern, 7:30-9am Pacific
Psychiatric drug withdrawal in Israel's Soteria House programs

January 15, 2019: Roger Mulder, MD
4:30-6pm Eastern, 1:30-3pm Pacific
Antidepressant withdrawal study: Results, protocols used, and lessons learned from it.

These topics are among the least understood and most critical issues facing psychiatry in the decades ahead given the fact that well-constructed unbiased research shows clearly that most individuals do better in the mid- to long-term if they can reduce their reliance on psychiatric medications.

SPEAKERS

June 19, 2018
Robert Whitaker is an American journalist and author who has won numerous awards as a journalist covering medicine and science, including the George Polk Award for Medical Writing and a National Association for Science Writers’ Award for best magazine article. In 1998, he co-wrote a series on psychiatric research for the Boston Globe that was a finalist for the Pulitzer Prize for Public Service. His first book, Mad in America, was named by Discover magazine as one of the best science books of 2002. Anatomy of an Epidemic won the 2010 Investigative Reporters and Editors book award for best investigative journalism. He is the publisher of madinamerica.com.

Tricia Williams, MD is an integrative family physician, who while currently parenting full time, is passionate about the integration of conventional and complementary approaches to improve health. Dr. Williams lectures frequently on emotional well being without the harmful use of psychiatric drugs.

Stuart Shipko, MD is a psychiatrist in private practice in Pasadena, CA and author of Surviving Panic Disorder and Xanax Withdrawal. Drawn from his clinical experience, his blog concerns adverse effects of SSRI antidepressants, particularly withdrawal related effects.

Laurie Oakley is a person with lived experience who was prescribed SSRI’s for her depression in the 1990’s, which caused cognitive difficulties, suicidal ideation, and panic attacks. She was then prescribed Klonopin for the panic attacks, which left her with chronic, untreatable insomnia. Her memoir, Crazy and It Was, interweaves journal entries on her experiences with psychiatric drugs with research studies on psychiatric medication and information about the influence of the pharmaceutical industry. Now she leads a withdrawal group in her community, a vital resource for people coming off psychiatric drugs.

July 17, 2018

Joanna Moncrieff, M.D. is a psychiatrist, academic and author. She has an interest in the history, philosophy and politics of psychiatry, and particularly in the use, misuse and misrepresentation of psychiatric drugs. As an author, Dr. Moncrieff has written extensively on psychiatric drugs and her books include The Myth of the Chemical Cure, A Straight Talking Introduction to Psychiatric Drugs and The Bitterest Pills: the troubling story of antipsychotic drugs. She is one of the founding members of the Critical Psychiatry Network which consists of psychiatrists from around the world who are skeptical of the idea that mental disorders are simply brain diseases and of the dominance of the pharmaceutical industry.

August 21, 2018
Sandra Steingard, M.D. is Associate Clinical Professor of Psychiatry at University of Vermont Larner College of Medicine and Chief Medical Officer at Howard Center, a community mental health center in Burlington, Vermont where she has worked for the past 22 years. For over 25 years her clinical practice has primarily included patients with schizophrenia and other psychotic illnesses. She was named to Best Doctors in America in 2003. She currently writes a blog called “Anatomy of a Psychiatrist” a http://www.madinamerica.com. She has served on the board of the Foundation for Excellence in Mental Health Care since 2012 and has served as chair since 2016.

In recent years, her main areas of interest have been in using antipsychotic drugs in a more selective ways and integrating Open Dialogue practices into her clinic. Along with colleagues, she has developed a Vermont-based need-adapted program called Collaborative Network Approach. Dr. Steingard has presented a previous course for Mad In America Continuing Education, “Antipsychotics: Short and Long-term Effects.” She has lectured around the world on these topics. She chaired a workshop and symposium at American Psychiatric Association meetings on the optimal use of antipsychotic drugs. She has tracked a series of individuals who have been tapering their doses of antipsychotic drugs and will present this data in this lecture.

September 18, 2018

David Healy, M.D. is an internationally respected psychiatrist, psychopharmacologist, scientist, and author. A professor of psychiatry in Wales, David studied medicine in Dublin, and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology and has authored more than 200 peer-reviewed articles and 20 books, including The Antidepressant Era, The Creation of Psychopharmacologyand his latest book, Pharmageddon, published in 2012. David is a founder and CEO of Data Based Medicine Limited, which operates through its website RxISK.org, and is dedicated to making medicines safer through online direct patient reporting of drug side effects.

Johanna Ryan is a workers’ comp paralegal and a union and healthcare activist in Chicago. She may or may not have a biological brain disease, but she is definitely allergic to capitalism and addicted to asking questions.

October 16, 2018
Sami Timimi, M.D. is a Consultant Child and Adolescent Psychiatrist and a Visiting Professor of Child and Adolescent Psychiatry based in Lincoln, UK. He writes from a critical psychiatry perspective and has published many articles and books including Naughty Boys: Anti-Social Behaviour, ADHD, and the Role of Culture (2005), A Straight Talking Introduction to Children’s Mental Health Problems (2009) and most recently The Myth of Autism: Medicalising Men’s and Boys’ Social and Emotional Competence (2010). He is founder member of the International Critical Psychiatry Network and recently launched the No More Psychiatric Labels campaign to abolish formal psychiatric diagnostic systems.

November 20, 2018
Swapnil Gupta, M.D., M.B.B.S., is a psychiatrist who received most of her foundational training in medicine and psychiatry in Pondicherry and Chandigarh in India. She completed a second residency and a psychopharmacology fellowship at SUNY Downstate and Yale. Her interest in deprescribing emerges from a critical clinical need for such an intervention in psychiatry, her experience of having worked in settings with limited access to medications and her strong inclination toward rational and parsimonious use of medications. She works as Assistant Professor of Psychiatry at the Yale School of Medicine where she teaches clinical interviewing and psychopharmacology to medical students and psychiatry residents. She also works as outpatient attending psychiatrist at the Connecticut Mental Health Center.

December 11, 2018
Pesach Lichtenberg, M.D., is a Jerusalem psychiatrist and former Head of Psychiatry at the medical school of the Hebrew University in Jerusalem, where he continues to serve as Clinical Associate Professor. He left his position as head of a closed psychiatric ward in order to establish Soteria Israel, which currently operates two Soteria homes in Jerusalem.

January 15, 2019

Roger Mulder, MBChB, PhD is a Professor of Psychological Medicine at the University of Otago. His academic interests include mood disorders, personality disorders, genetics, neurobiology, suicide, and early psychosis. He is interested in the history and philosophy of psychiatry, particularly the classification of abnormal behaviour. Dr. Mulder is also involved in research on the psychiatric aspects of medical illnesses. He has published over 150 articles and book hapters. He is editor of the journal Personality and Mental Health, associate editor of the New Zealand Medical Journal and serves on several editorial boards.

Enroll in Webinar TODAY!

For more information, contact Bob Nikkel at bobnikkel@gmail.com or (503) 929-9346.

We hope to see you there!

Best regards,

Robert Nikkel
Executive Director
Mad in America Continuing Education"
RIP Ali 23 years old
RIP Kevin Goodreau 28 years old
RIP Petar 23 years old
RIP Mary Koback 22 years old
RIP David Stofkooper 23 years old
RIP SadBoy
RIP Kata Balint 28 years old
GIXXER
Posts: 658
Joined: Mon Apr 25, 2016 4:29 pm
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by GIXXER »

I just realized I have about $100,000 saved away. I should put the challenge out for myself that if I can be cured 100% back to normal function pre pssd Ill award to wgo ever cures me.
GIXXER
Posts: 658
Joined: Mon Apr 25, 2016 4:29 pm
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by GIXXER »

Is Dr Healy basically the Dr for Public Relations on PSSD? We definitely should try to get him on vice.com and the Joe Rogan Podcast. If we could do this it would be huge for us and PSSD.
REVOLUTIONIZE
Posts: 33
Joined: Fri Sep 06, 2019 9:29 am
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by REVOLUTIONIZE »

Right, so we have raised $63,430 so far, still over 35k to go. COME ON EVERYONE, LET'S DONATE EVEN A SMALL AMOUNT EVERY MONTH, CONSISTENLY.

After reaching the goal, we could make some noise about the prize and attract media. Dr Healy is 66 years old already, he will not be able to keep on helping us forever. WE MUST GET TO 100K THIS YEAR GUYS.
Trazohell
Posts: 215
Joined: Fri Jan 26, 2018 11:46 am

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by Trazohell »

Still only 63000 $ after over two years. Most seem to be fine with pssd.
June 2015 - April 2016 Fluoxetine
April 2016 - March 2017 Fluvoxamine
December 2017 9 days Trazodone
After Trazodone PSSD: loss of libido & spontaneous/night/morning erections, prostate/pelvic pain, genital numbness, lower sperm count, Anhedonia
REVOLUTIONIZE
Posts: 33
Joined: Fri Sep 06, 2019 9:29 am
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by REVOLUTIONIZE »

Look how many people donated - only 163. Nearly 600 reported PSSD to Rxisk, if they all could donate 3 quid or dollars a month, that's over 20 k a year. Don't buy a big mac and donate a small amount like £3 every month. That is definitely an amount that everyone here can afford. For UK or other countries with high GDP, $10 dollars a month would be peanuts.
climb
Posts: 170
Joined: Sun Dec 29, 2019 10:09 pm
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by climb »

It's a good point.

If everyone set up a small monthly donation, that's be the best way to go.
I will certainly do this.
REVOLUTIONIZE
Posts: 33
Joined: Fri Sep 06, 2019 9:29 am
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by REVOLUTIONIZE »

Two more people donated and the amount increased by $500 - good sign.
Frog
Posts: 292
Joined: Sun Feb 24, 2019 2:37 pm
Contact:

Re: RXISK Issues $100,000 Prize for the Cure For PSSD

Unread post by Frog »

Before investing all of your money in this I’d recommend waiting for Meso to outline his research proposal. It’s the best chance at PSSD research that we’re ever likely to get. It will he conducted at his former university meaning we can cut out many costs but we still need to pay for staff. More details can be found on the discord server shared by TalkingAnt.
Post Reply

Who is online

Users browsing this forum: No registered users and 5 guests